Potential applicants are asked to complete a pre-application form, following an expression of interest in a TACT review. Pre-applications are reviewed by the Chair and Secretariat who assess their suitability to progress to a full application and review. To request a pre-application form or discuss aspects of the process, please contact Cathy Turner.
Full applications are completed via an online system approximately 3-4 months prior to the review meeting. Completing the application focuses the applicant on a number of important considerations including; scientific rationale, the appropriateness and interpretation of the nonclinical studies performed; safety and toxicology issues; drug distribution and kinetics; feasibility and cost of drug manufacturing and supply; context of project in the clinical development plan and regulatory consideration critical to advancing a compound into clinic.
For academic groups working on treatments or platform technologies for Duchenne muscular dystrophy: Financial support is available to cover a portion of meeting costs as well as travel and accommodation for eligible individuals or groups. This support is provided via a fund from CureDuchenne. To inquire further, or to request this financial support, please contact Cathy Turner.
A sample version of the TREAT-NMD Advisory Committee for Therapeutics Application form is available to download. This sample form is intended to be used for reference purposes only and is a static version of the online form which should be used to submit applications.
If you wish to submit an application please contact Cathy Turner for details and access to the online form.